# Humana (HUM) — Analyst Forecast

HUM · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/hum/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 16 | 13 | 1 | 30 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $370.00 | $479.38 | $596.00 | 13 |

Last price $432.20 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | Mizuho | Maintained | Outperform | $495.00 |
| Oct 12, 2026 | Raymond James | Upgraded | Market Perform → Outperform | $520.00 |
| Oct 12, 2026 | Oppenheimer | Maintained | Outperform | $525.00 |
| Oct 12, 2026 | Truist Securities | Maintained | Hold | $475.00 |
| Oct 12, 2026 | UBS | Maintained | Neutral | $495.00 |
| Oct 9, 2026 | Baird | Upgraded | Neutral → Outperform | $596.00 |
| Oct 9, 2026 | Oppenheimer | Maintained | Outperform | $475.00 |
| Oct 9, 2026 | Barclays | Maintained | Overweight | $582.00 |
| Oct 7, 2026 | Cantor Fitzgerald | Upgraded | Neutral → Overweight | $460.00 |
| Sep 25, 2026 | Barclays | Upgraded | Equal-Weight → Overweight | $515.00 |
| Aug 10, 2026 | JP Morgan | Maintained | Neutral | $393.00 |
| Aug 5, 2026 | Morgan Stanley | Upgraded | Underweight → Equal-Weight | $370.00 |
| Jul 31, 2026 | Barclays | Maintained | Equal-Weight | $407.00 |
| Jul 31, 2026 | TD Cowen | Maintained | Hold | $370.00 |
| Jul 30, 2026 | Raymond James | Downgraded | Outperform → Market Perform | — |
| Jul 30, 2026 | Evercore ISI Group | Upgraded | In-Line → Outperform | $480.00 |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | $471.00 |
| Jul 30, 2026 | UBS | Maintained | Neutral | $405.00 |
| Jul 14, 2026 | Truist Securities | Maintained | Hold | $415.00 |
| Jul 14, 2026 | TD Cowen | Maintained | Hold | $350.00 |

## Frequently Asked Questions

### What is the price target for HUM stock?

The average 12-month analyst price target for Humana (HUM) is $479.38, with a high estimate of $596.00 and a low of $370.00, across 13 analysts.

### Is HUM a buy, sell, or hold?

Analysts covering Humana currently average a Buy rating: 16 buy, 13 hold and 1 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for HUM?

The average price target of $479.38 implies 10.92% upside from the last price of $432.20.

### What is the latest analyst rating on HUM?

On Oct 13, 2026, Mizuho maintained Humana at Outperform with a price target of $495.00.

## Similar Stocks

- [CNC](https://www.lighthorse.io/tickers/cnc) — Centene Corporation Common Stock
- [CI](https://www.lighthorse.io/tickers/ci) — The Cigna Group Common Stock
- [MOH](https://www.lighthorse.io/tickers/moh) — Molina Healthcare Inc Common Stock
- [ELV](https://www.lighthorse.io/tickers/elv) — Elevance Health, Inc. Common Stock
- [UNH](https://www.lighthorse.io/tickers/unh) — UnitedHealth Group Incorporated Common Stock (DE)

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).